COMPANY PROFILE

Cartography Biosciences

Shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets

Foster City, United StatesFounded 2020Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2025

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Cartography Biosciences

Cartography.bio is a pioneering startup operating in the field of cancer therapeutics. The company's primary focus is on developing cancer immunotherapies that are as precise as their targets. They aim to design treatments that are not only safe but also highly effective. The company serves a broad range of clients, including healthcare providers and patients, particularly those suffering from various types of cancer.

Read full description

The company operates in the healthcare market, specifically in the cancer therapeutics sector. It uses a unique approach to target identification, analyzing cancers through the lens of antigen expression rather than histology or genetic mutations. This innovative method allows the company to identify potential targets for cancer treatment that were previously overlooked.

Cartography.bio's business model revolves around the development and commercialization of precision cancer therapeutics. The company generates revenue by creating and selling these innovative therapies. They also aim to find druggable targets for cancers that are currently untreatable and create therapeutics that are specific enough to only engage tumor cells, broad enough to target every cell in a patient’s tumor, and safe enough to minimize toxic side effects.

In summary, Cartography.bio is a forward-thinking startup that is revolutionizing the field of cancer therapeutics by developing precise and effective immunotherapies. The company's unique approach to target identification and its commitment to creating safe and effective treatments make it a promising player in the healthcare market.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Foster City, United States
Employees: 67
Open positions: 2
Dealroom signal: 85.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Cartography Biosciences.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
LATE VCOther financing	May 2026	$0	—	Samsung Ventures	↗
SERIES BOther financing	Oct 2025	$67M	$268M	Andreessen Horowitz · Wing Venture Capital · Artis Ventures · Gaingels	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Cartography Biosciences website traffic

Latest recorded traffic for Cartography Biosciences is 4.9K monthly website visits, down 5.8% over the last three months. Cartography Biosciences's team grew 11.7% over the past year.

Latest monthly visits4.9K 3-month web change-5.8% 1-year team growth+11.7%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

Associate Director / Director, Protein SciencesSouth San Francisco, California, United States, Northern America, Americas · Other · Jul 10, 2026 Executive Director/Vice President, Finance & ControllerSouth San Francisco, California, United States, Northern America, Americas · Finance · Jul 8, 2026 Senior Clinical Trial ManagerFoster City, San Mateo County, California, United States · Other · Sep 20, 2025

3 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RBRidge BiotechnologiesAI-enabled platform for precision enzyme and drug design	Palo Alto, United States	Operational	15	$25M	$100M
3S32 Biosciences "Three Squared"Three Squared Biosciences is leveraging artificial intelligence to better understand the gut microbiome, and utilizing this information to create therapies that	United States	Operational
DADiagen AIAI-driven protein design platform for health science	Vancouver, Canada	Operational
ARArontierInnovative AI-driven solutions targeting cancer treatment through precision medicine and anti-CAF drug development	Seoul, South Korea	Operational
HLHangzhou Dunen Medical Testing LaboratoryA clinical precision medication guidance service provider	Hangzhou, China	Operational
YTYsotope TheranosticsTargeted radiopharmaceuticals for precision oncology	Madrid, Spain	Operational
TBTome BiosciencesTome Biosciences is the programmable gene insertion company	Watertown, United States	Operational
PHPhenomicshealthAn Artificial Intelligence-Powered Patient-Focused Precision Medicine company	Plymouth, United States	Operational